Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fi
scientific article published on 26 August 2016
Author/s
author: Deepak L. Bhatt, Gregory Lip, Stephen G. Ellis, Jonas Oldgren, Christopher P Cannon, Joseph M. Massaro, Stefan H Hohnloser, Philippe Gabriel Steg, RE-DUAL PCI Steering Committee and Investigators, Jurrien ten Berg
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.